Drug Name:
MAALOX MAX STR OTC
Generic Name and Formulations:
Aluminum hydroxide 500mg, magnesium hydroxide 450mg, simethicone 40mg; per 5mL; liq; mint or cherry flavor.
Company:
Novartis Consumer Health
Therapeutic Use:
Indications for MAALOX MAX STR:
Heartburn, acid indigestion, sour stomach, upset stomach.
Adult:
10–20mL 4 times daily; max 60mL/day.
Children:
Not recommended.
Warnings/Precautions:
Impaired renal function (aluminum/magnesium forms).
See Also:
MAALOX THERAPEUTIC CONCENTRATE
Pharmacological Class:
Antacid + antiflatulent.
Interactions:
Reduces absorption of tetracyclines, possibly other drugs.
How Supplied:
Susp (mint)—5oz, 12oz, 26oz; Susp (lemon, cherry)—12oz, 26oz; Therapeutic Conc—12oz; Tabs (berry, wintergreen)—45, 85; Tabs (lemon)—30, 45, 85; Max Str tabs—35, 65; Max Str susp (lemon)—5oz, 12oz, 26oz; Max Str susp (mint, cherry)—12oz, 26oz
Sign Up for Free e-newsletters
ONA Articles
- FDA: Number of U.S. Women With Breast Implant-Caused Cancer Has Increased
- Takeda to Collaborate With MSKCC on CAR-T Therapies for Multiple Myeloma
- Sequential Immunotherapy, Targeted Therapy Linked to Cutaneous Adverse Events in Advanced Melanoma
- Immunotherapy for HER2-positive Breast Cancer: Recent Advances and Combination Therapeutic Approaches
- NIH Establishes Educational Program on Genomics, Genetics for Oncology Nurses
- Oncology Nurse Navigation Facilitates Timely Treatment of Pancreatic Cancer
- Helping Patients Face the Challenge of Eating Healthy During Cancer Treatment
- Oncology Nurses Weigh In on Their Patient-Centered Communication Practices, Needs
- Substitute for Lidocaine
- CART cell therapy for prostate cancer: status and promise
- Immunotherapy for HER2-positive Breast Cancer: Recent Advances and Combination Therapeutic Approaches
- Survey Demonstrates Relationship Between Symptom Burden, Medical Disability Leave Among Myeloproliferative Neoplasms
- A Review of Clinical Outcomes in Patients With Early-Stage Burkitt Lymphoma
- FDA: Number of U.S. Women With Breast Implant-Caused Cancer Has Increased
- USPSTF Still Recommends Against Pancreatic Cancer Screening
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
| Bone Cancer | Regimens | Drugs |
| Brain Cancer | Regimens | Drugs |
| Breast Cancer | Regimens | Drugs |
| Endocrine Cancer | Regimens | Drugs |
| Gastrointestinal Cancer | Regimens | Drugs |
| Genitourinary Cancer | Regimens | Drugs |
| Gynecologic Cancer | Regimens | Drugs |
| Head and Neck Cancer | Regimens | Drugs |
| Hematologic Cancer | Regimens | Drugs |
| Lung Cancer | Regimens | Drugs |
| Other Cancers | Regimens | |
| Rare Cancers | Regimens | |
| Skin Cancer | Regimens | Drugs |